Facebook Twitter Instagram
    • About
    • Subscribe
    • Contact
    • Report Library
    • Manager Login
    Facebook Twitter LinkedIn RSS
    HedgeNordic
    • Home
    • Allocator Angle
    • Report Library
    • Nordic Hedge Award
      • Nominations 2021 Nordic Hedge Award
      • Rookie of the Year
      • Jury Board
      • Historic Winners
      • Statistics
    • Nordic Hedge Index
    • Webinars & Podcasts
    HedgeNordic

    Coeli Enjoys Atai Success

    Eugeniu GuzunBy Eugeniu Guzun29/06/2021No Comments
    Facebook Twitter LinkedIn Email

    Stockholm (HedgeNordic) – Germany-based biotech Atai Life Sciences, backed by billionaire investor Peter Thiel, Mike Novogratz, Atai founder Christian Angermayer’s own family office and smaller investors such as Malmö-based money manager Mikael Petersson, went public last week on the NASDAQ. The psychedelics biotech start-up’s shares currently trade above $18 apiece, translating into a market capitalization of about $2.8 billion.

    Mikael Petersson, Portfolio Manager of Coeli Absolute European Equity

    In September 2018, the biotech start-up completed a Series A financing round of $24.4 million to make psychedelic drugs to treat mental health disorders. Long/short equity fund Coeli Absolute European Equity, founded and managed by Mikael Petersson out of Malmö, invested close to $1 million in the Series A round alongside a select group of investors that also featured well-known entrepreneur and venture capitalist Peter Thiel. After a Series B financing round of $43 million in March of last year, a $125 million Series C financing at the end of 2020 and a Series D fundraising of $157 million earlier this year, ATAI Life Sciences raised an additional $225 million through its initial public offering last week at the IPO price of $15.

    “Committed to our public mission, now more than ever. atai Life Sciences is now a public company, listed on Nasdaq — a huge step for us, but we have so much work to do.”

    “Committed to our public mission, now more than ever. atai Life Sciences is now a public company, listed on Nasdaq — a huge step for us, but we have so much work to do,” Atai Life Sciences writes on LinkedIn post. “Becoming a public company will help atai access the resources necessary to deliver on our goals, to deliver positive impact and improved treatment options for mental health disorders.”

    “Becoming a public company will help atai access the resources necessary to deliver on our goals, to deliver positive impact and improved treatment options for mental health disorders.”

    “The world we’re building is a bad place for our brain, so mental health issues will go up. But I do think we have some real shots in our portfolio to end the mental health crisis,” Atai’s founder and Chairman, Christian Angermayer, said on CNBC’s “Squawk Box” on Friday last week. Atai Life Sciences is the brainchild of Angermayer, who was joined by co-founder and current CEO Florian Brand to “enable people to live healthier and happier lives” by “bringing back formerly vilified drugs like psychedelics into the legal realm.”

    “We are very proud and grateful of being an early investor in Atai Life Sciences AG. A company with the very important mission to end the mental health crisis in the world.”

    “From a dinner in Copenhagen to today’s form and shape in less than three years. Incredible!”

    “We are very proud and grateful of being an early investor in Atai Life Sciences AG. A company with the very important mission to end the mental health crisis in the world,” says Petersson, the founder and portfolio manager of Coeli Absolute European Equity. “From a dinner in Copenhagen to today’s form and shape in less than three years. Incredible!” he continues. “Big congratulations to Christian Angermayer and Florian Brand and the whole team for the success and we look forward to the coming years.”

    Image courtesy of Nasdaq

    Share. Facebook Twitter LinkedIn Email
    Previous ArticleThe Atlas Global Macro App
    Next Article Calgus: Concentrated and Unconstrained
    Eugeniu Guzun

    Eugeniu Guzun serves as a data analyst responsible for maintaining and gatekeeping the Nordic Hedge Index, and as a journalist covering the Nordic hedge fund industry for HedgeNordic. Eugeniu completed his Master’s degree at the Stockholm School of Economics in 2018.

    Related Posts

    SRV Hires New Portfolio Manager

    AIM Capital Hires Portfolio Manager

    A Fundamental Formula: Focus on Valuation

    Add A Comment

    Leave A Reply Cancel Reply

    Time limit is exhausted. Please reload CAPTCHA.

    Most read today:
    • Johanne Schordin Leaves RPM to Join Brummer & Partners
    • Nordic Hedge Award – Main
    • Trient Global Macro Shuts Its Doors
    • AFII Appoints Head of Portfolio Strategy
    • Danish Hedge Funds Lead the Way
    • Othania to Launch All-Weather Equity Fund
    • In-Depth: Inflation Protection

    Ukraine, Supply-Chain Shortages and Soaring Prices – Accelerators of Sustainable Development

    18/05/2022

    New Theme: Real Income Destruction

    17/05/2022

    Blockification

    16/05/2022

    The Inflation Puzzle

    12/05/2022
    Promotion:
    Video: Manager Interviews
    https://www.youtube.com/watch?v=tni7dQvQrmo

    Subscribe to our newsletter

    HedgeNordic: Your Single Access Point to the Nordic Hedge Fund Industry!

    Check your inbox now to confirm your subscription.

    Most read articles this week:
    • SRV Hires New Portfolio Manager
    • Othania to Launch All-Weather Equity Fund
    • New Theme: Real Income Destruction
    • Nykredit Hires Head of Alts
    • AIM Capital Hires Portfolio Manager
    • Blockification
    • Recent
    • NHX
    • In Depth

    Johanne Schordin Leaves RPM to Join Brummer & Partners

    23/05/2022

    SRV Hires New Portfolio Manager

    19/05/2022

    Othania to Launch All-Weather Equity Fund

    19/05/2022

    Ukraine, Supply-Chain Shortages and Soaring Prices – Accelerators of Sustainable Development

    18/05/2022

    Month in Review – April 2022

    12/05/2022

    Follow Your Favourite Hedge Fund

    11/05/2022

    Month in Review – March 2022

    13/04/2022

    Month in Review – February 2022

    10/03/2022

    Ukraine, Supply-Chain Shortages and Soaring Prices – Accelerators of Sustainable Development

    18/05/2022

    New Theme: Real Income Destruction

    17/05/2022

    Blockification

    16/05/2022

    The Inflation Puzzle

    12/05/2022
    Newsletter Subscription:
    Most Recent Posts:

    Johanne Schordin Leaves RPM to Join Brummer & Partners

    23/05/2022

    SRV Hires New Portfolio Manager

    19/05/2022

    Othania to Launch All-Weather Equity Fund

    19/05/2022

    Ukraine, Supply-Chain Shortages and Soaring Prices – Accelerators of Sustainable Development

    18/05/2022

    Nykredit Hires Head of Alts

    17/05/2022
    Publisher

    Nordic Business Media AB
    Corporate No.: 556838-6170
    BOX 7285
    SE-103 89 Stockholm, Sweden

    VAT No.: SE-556838617001
    Tel.:+46 (0) 8 5333 8688
    Mob.: +46 (0) 7 06566688
    Email: info@hedgenordic.com

    STAY INFORMED

    HedgeNordic: Your Single Access Point to the Nordic Hedge Fund Industry!

    Subscribe to our newsletter:

    Check your inbox now to confirm your subscription.

    RSS Hedge Fund Job Digest
    • Fund Controller 23/05/2022
    • Manager or Senior Manager, Alternative Investment Valuations 23/05/2022
    • Portfolio Analytics Analyst 23/05/2022
    • Data Analyst 23/05/2022
    • Fund Accountant 23/05/2022
    • Associate - Fund Operations 23/05/2022
    • Senior Analyst 23/05/2022
    • Valuations Analyst 23/05/2022

    Copyright © 2022 Nordic Business Media AB

    © 2022 Nordic Business Media AB
    • About
    • Cookie Policy
    • Privacy Policy

    Type above and press Enter to search. Press Esc to cancel.

    We are using cookies to give you the best experience on our website.

    HedgeNordic
    Powered by  GDPR Cookie Compliance
    Privacy Overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

    Strictly Necessary Cookies

    Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

    If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.